These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24331797)

  • 1. Body fluid biomarkers in multiple sclerosis.
    Comabella M; Montalban X
    Lancet Neurol; 2014 Jan; 13(1):113-26. PubMed ID: 24331797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood and cerebrospinal fluid biomarkers in MS/NMO].
    Nakatsuji Y
    Nihon Rinsho; 2014 Nov; 72(11):1970-5. PubMed ID: 25518379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
    Salvisberg C; Tajouri N; Hainard A; Burkhard PR; Lalive PH; Turck N
    Proteomics Clin Appl; 2014 Apr; 8(3-4):185-94. PubMed ID: 24488530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body fluid biomarkers for multiple sclerosis--the long road to clinical application.
    Teunissen CE; Malekzadeh A; Leurs C; Bridel C; Killestein J
    Nat Rev Neurol; 2015 Oct; 11(10):585-96. PubMed ID: 26392381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of biomarkers for multiple sclerosis as a neurodegenerative disorder.
    Ziemann U; Wahl M; Hattingen E; Tumani H
    Prog Neurobiol; 2011 Dec; 95(4):670-85. PubMed ID: 21524682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.
    Colomba P; Fontana S; Salemi G; Barranca M; Lo Sicco C; Mazzola MA; Ragonese P; Savettieri G; De Leo G; Alessandro R; Duro G
    Int J Mol Sci; 2014 Dec; 15(12):23269-82. PubMed ID: 25517032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis.
    Awad A; Hemmer B; Hartung HP; Kieseier B; Bennett JL; Stuve O
    J Neuroimmunol; 2010 Feb; 219(1-2):1-7. PubMed ID: 19782408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of disease activity in multiple sclerosis.
    Graber JJ; Dhib-Jalbut S
    J Neurol Sci; 2011 Jun; 305(1-2):1-10. PubMed ID: 21463872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
    Teunissen C; Menge T; Altintas A; Álvarez-Cermeño JC; Bertolotto A; Berven FS; Brundin L; Comabella M; Degn M; Deisenhammer F; Fazekas F; Franciotta D; Frederiksen JL; Galimberti D; Gnanapavan S; Hegen H; Hemmer B; Hintzen R; Hughes S; Iacobaeus E; Kroksveen AC; Kuhle J; Richert J; Tumani H; Villar LM; Drulovic J; Dujmovic I; Khalil M; Bartos A
    Mult Scler; 2013 Nov; 19(13):1802-9. PubMed ID: 23695446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
    Teunissen CE; Dijkstra C; Polman C
    Lancet Neurol; 2005 Jan; 4(1):32-41. PubMed ID: 15620855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarkers in multiple sclerosis].
    Fernández Ó; Arroyo-González R; Rodríguez-Antigüedad A; García-Merino JA; Comabella M; Villar LM; Izquierdo G; Tintoré M; Oreja-Guevara C; Álvarez-Cermeño JC; Meca-Lallana JE; Prieto JM; Ramió-Torrentà L; Martínez-Yélamos S; Montalban X
    Rev Neurol; 2013 Apr; 56(7):375-90. PubMed ID: 23520007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
    Baranowska-Bik A; Kochanowski J; Uchman D; Wolinska-Witort E; Kalisz M; Martynska L; Baranowska B; Bik W
    J Neuroimmunol; 2013 Oct; 263(1-2):159-61. PubMed ID: 24041830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.
    Raphael I; Webb J; Stuve O; Haskins W; Forsthuber T
    Expert Rev Clin Immunol; 2015 Jan; 11(1):69-91. PubMed ID: 25523168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward biomarkers in multiple sclerosis: new advances.
    Lolli F; Rovero P; Chelli M; Papini AM
    Expert Rev Neurother; 2006 May; 6(5):781-94. PubMed ID: 16734525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilaments as biomarkers in multiple sclerosis.
    Teunissen CE; Khalil M
    Mult Scler; 2012 May; 18(5):552-6. PubMed ID: 22492131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica and multiple sclerosis.
    Zhang H
    Mult Scler; 2011 May; 17(5):639-40; author reply 641. PubMed ID: 21382861
    [No Abstract]   [Full Text] [Related]  

  • 17. Myelin basic protein in multiple sclerosis and other neurological disorders.
    Kalistová H; Havrdová E; Uhrová J; Zeman D; Týblová M; Mrázová K
    J Neurol; 2003 Jul; 250(7):874-5. PubMed ID: 12883934
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.
    El Ayoubi NK; Khoury SJ
    Neurotherapeutics; 2017 Jan; 14(1):135-147. PubMed ID: 27757816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid analysis in the 2010 revised McDonald's multiple sclerosis diagnostic criteria.
    Galea I; Freedman MS; Thompson EJ
    Ann Neurol; 2011 Jul; 70(1):183; author reply 183-4. PubMed ID: 21786311
    [No Abstract]   [Full Text] [Related]  

  • 20. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
    Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
    J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.